Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SR has clawed back most of September's losses this week, but the analyst community is quietly trimming its ambitions for the stock even as options hedging eases off its recent peak.
The price recovery is real but modest. Spire added 2.3% on the week to close at $77.82, reversing some of the 7% slide that defined September. The one-month picture still shows a 5.9% loss, and the stock remains well below the $88 to $103 range that several analysts have pencilled in as fair value. The last note on this stock, published September 30, flagged options positioning as the dominant signal, with put/call running more than two standard deviations above its 20-day average. That pressure has eased. The put/call ratio has pulled back to 0.77 from 0.78, the z-score has dropped to 1.06, still above the 20-day mean of 0.71 but no longer in the elevated zone that drew attention last week. Options traders are less defensive, not outright bullish.
The borrow market tells the same low-stress story it has all year. Availability remains extraordinarily loose at over 2,100%, meaning the lending pool holds roughly 21 shares available for every one currently borrowed, far above even the tightest reading of the past 52 weeks, which was 663%. Borrowing costs have edged up about 0.9% on the week to 0.52%, but the absolute level is negligible. Short interest at 4.8% of the free float has crept up 0.5% on the week and about 9% over the past month, but that monthly build is gradual rather than aggressive, and the ORTEX short score of 43.9 sits in the middle of its range with no sharp directional move. There is nothing in the positioning data to suggest a catalyst-driven short thesis building.
The more interesting development is on the Street. The analyst consensus has settled at hold, with five analysts at that rating and no buys or sells on the current book. Scotiabank initiated at Sector Perform with a $79 target just nine days ago, essentially matching the current price, which is a signal that the new entrant sees little near-term upside. Morgan Stanley, which remains the most prominent bull with an Overweight rating, cut its target a second consecutive time in September, moving from $96 in August to $91 and then to $88. The mean target now stands at $91.40, implying roughly 17% upside from current levels, but the direction of travel among recent moves is clearly downward. JP Morgan downgraded to Neutral in late June even while raising its target slightly to $85, and the gap between the current price and that target has narrowed as the stock declined. The EV/EBITDA multiple has compressed about 1.4 turns over the past month to 8.7x, while the PE has fallen more than 3.6 points to around 13x, reflecting both the share price decline and some earnings estimate revision. The dividend factor score ranks at 88th percentile, supporting the utility's income credentials, but the EPS surprise score of just 1st percentile and a deeply negative forward EPS growth reading are the balance-sheet headwinds the bears point to.
The bull and bear cases are well-worn at this point. Bulls highlight the ISRS mechanism, which recovers infrastructure investment costs through surcharges and limits regulatory lag, and point to the MoGas and Omega midstream acquisitions as adding a growth dimension to what is otherwise a pure regulated utility. Bears flag the weather dependency, the potential STL Pipeline shutdown risk, and the rising rate environment pressing on both capital costs and the yield-seeking investor base that typically supports gas utilities. BlackRock holds 14.5% and added 571,000 shares through September, a meaningful incremental buy from the largest holder. State Street also added 167,000 shares. Both moves suggest passive and quasi-passive flows remain supportive at current levels, even as some active managers, including Adage and CapFinancial, trimmed through mid-year.
Wikipedia attention for Spire has been running well above its own 90-day history, with a z-score of 2.26 through late September. For a mid-cap regulated utility that rarely generates mainstream headlines, the spike in retail interest is worth noting, though it is a measure of attention rather than a financial signal.
The next scheduled event is Q4 earnings on November 18, 41 days away. The only prior print in the history provided, Q3 results on August 5, produced a 1.6% gain on the day and a nearly 4% gain over the following five sessions. With the stock still 5% below its one-month high and the Street steadily revising targets lower, the question heading into November is whether the current $77 to $79 range holds as a floor or becomes resistance.
See the live data behind this article on ORTEX.
Open SR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.